No abstract available
Publication types
-
Case Reports
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Aged
-
Antineoplastic Agents / therapeutic use
-
Bridged Bicyclo Compounds, Heterocyclic / pharmacology*
-
Clinical Trials, Phase II as Topic
-
Disease Progression
-
Drug Resistance, Neoplasm*
-
Female
-
High-Throughput Nucleotide Sequencing
-
Humans
-
Leukemia, Lymphocytic, Chronic, B-Cell / drug therapy*
-
Leukemia, Lymphocytic, Chronic, B-Cell / genetics*
-
Mutation*
-
Neoplasm Recurrence, Local
-
Neoplasm, Residual
-
Proto-Oncogene Proteins c-bcl-2 / genetics*
-
Risk
-
Sulfonamides / pharmacology*
Substances
-
Antineoplastic Agents
-
BCL2 protein, human
-
Bridged Bicyclo Compounds, Heterocyclic
-
Proto-Oncogene Proteins c-bcl-2
-
Sulfonamides
-
venetoclax